Categories AlphaGraphs, Earnings, Other Industries

Earnings: Owens Corning stock gains 1% on market-beating Q4 results

Shares of Owens Corning (OC) gained modestly during pre-market trading on Wednesday, after the company delivered better-than-expected fourth quarter net sales of $1.72 billion, up 7% year-over-year. Wall Street had expected the insulation and roofing company to report net sales of just $1.68 billion.

Image courtesy: Owens Corning

In Q4, the company swung to a profit of $1.55 per share from a loss of $0.04 per share in the year-over period. Excluding one-off items, earnings grew 24% to $1.38 per share, surpassing the Street consensus of $1.29 per share.

Fourth quarter adjusted EBIT stood at $228 million, compared to $215 million in the prior-year quarter.

OC shares gained 1% immediately following the announcement of the results. The stock has lost almost 37% of its value in the trailing 52 weeks, hurt by the general weakness in the home-improvement market.

An infographic on Owens Corning's fourth quarter 2018 earnings results

CEO Mike Thaman said, “Owens Corning had another record year in terms of revenue and adjusted EBIT, with all three businesses delivering double-digit EBIT margins. Today, Owens Corning is a more resilient and diversified company, better able to generate attractive returns for investors through the cycle.”

It may be noted that COO Brian Chambers will succeed Mike Thaman as the company’s CEO, effective April 18.

For full-year 2019, the Toledo, Ohio-based firm has guided capital additions of about $500 million, with an increased focus on productivity improvements. It also anticipates strong conversion of adjusted earnings into free cash flow during this period.

General corporate expenses are projected in the range of $140 million to $150 million.

 

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference, and much more!

Most Popular

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Walgreens Boots Alliance set to report earnings next week. Here’s what to expect

Walgreens Boots Alliance, Inc. (NASDAQ: WBA), the drug store chain that is expanding into a diversified healthcare provider, is on a restructuring drive aimed at better aligning the business with

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top